Verity Advisors, LLC
Wendy E. Wifler is an experienced professional in the medical technology and healthcare industries, currently serving as Vice President of HEMA - Peripheral Interventions at Boston Scientific since July 2017. Wendy has held various leadership roles, including Vice President of Global Market Access at BTG and Vice President of U.S. Global Market Access at BTG plc prior to its acquisition by Boston Scientific. With a background in reimbursement strategy consulting at Verity Advisors Inc since 2010, Wendy has a strong focus on MedTech and clinical lab/molecular pathology. Additional experience includes serving on the AMA CPT CodeBridge™ Committee and strategic reimbursement roles at several healthcare companies. Wendy holds an Executive MBA with an entrepreneurial emphasis from Simmons College and a Bachelor of Science in Biological Sciences, along with a minor in Cognitive Psychology from UC Irvine.
This person is not in any teams
Verity Advisors, LLC
Verity Advisors is Financial Services company focused on the recovery and return of various assets to our clients. The firm creates a collaborative recovery strategy where our mission is single-minded: the timely, safe return of what is rightfully yours. Our clients rely upon us to successfully navigate the complex process of proving ownership on their behalf. Our firm is dedicated to providing exceptional service by customizing our recovery approach to each client. Whether your case is a directly owned asset, or several generations have passed, our team is dedicated to the successful return of your asset. With more than $40 Million dollars and over 200,000 shares of securities returned to our clients, we are the industry leading authority in our field. Mission Statement: Through integrity, hard work, and dedication, we resolve the complexities of reuniting our clients with what’s rightfully theirs.